134 Article(s)
1, 2, 3, 4, 5, 6 >> >|
Background: Methotrexate (MTX) remains the cornerstone for therapy for rheumatoid arthritis yet research shows that non-adherence is significant and correlates with response to therapy.
Objective: In order to develop interventions to optimise methotrexate (MTX) use for the treatment of rheumatoid arthritis (RA) we evaluated the rate of, reasons for and predictors of MTX non-adherence during the first six months of therapy.